Northwire Canada EditionTuesday, July 14, 2026
Sign inSubscribe
Northwire
⌕
WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8% WDO 26.04 −0.9% FVI 11.84 −1.6% OM 1.75 −1.7% ETG 2.99 +0.0% ARTG 31.47 −4.6% LUC 0.163 +1.6% AFM 1.38 +0.0% IMG 20.95 −3.5% CPAU 0.150 +3.5% MMX 0.075 +7.1% IE 12.47 −2.4% SASK 1.09 −1.8% MOG 0.390 +2.6% XIM 0.070 −6.7% S 0.110 −29.0% OMI 0.300 −4.8%
Earnings

TerrAscend Reports Third Quarter 2025 Financial Results

By The Northwire Desk — AI Analysis Nov 06, 2025 · 07:40 TSND · 0.97 TERRASCEND CORP. J
TSND · Price

Executive Summary

  • TerrAscend reported Q3 2025 net revenue of $65.1 M, essentially flat YoY, and a modest improvement in gross profit margin to 52.1% (+110 bps).
  • GAAP net loss from continuing operations narrowed to $9.9 M (vs. $15.8 M YoY) while Adjusted EBITDA rose to $17.0 M, delivering an Adjusted EBITDA margin of 26.1%.
  • The company completed a $79 M non‑dilutive refinancing and secured an uncommitted term loan facility up to $35 M for strategic M&A; cash balance increased to $36.6 M.

Key Details

  • Revenue & Margin
  • Net revenue: $65.1 M (Q2 2025: $65.0 M; Q3 2024: $65.2 M).

  • Gross profit margin (continuing ops): 52.1%, up 110 bps YoY.

  • Profitability

  • GAAP Net loss – continuing ops: $(9.9) M (vs. $(15.8) M YoY).
  • Adjusted EBITDA – continuing ops: $17.0 M (up from $16.0 M Q2 2025, down slightly vs. $16.9 M YoY).

  • Adjusted EBITDA margin: 26.1% (vs. 24.6% Q2 2025; 25.9% YoY).

  • Cash Flow

  • Net cash provided by continuing ops: $7.1 M (up from $6.1 M YoY).

  • Free Cash Flow: $4.9 M, marking the 9th consecutive quarter of positive free cash flow.

  • Financing Activity

  • Completed a $79 M senior secured syndicated term loan (non‑dilutive) – proceeds used to retire existing debt and fund growth initiatives.

  • Secured an additional uncommitted term loan facility of up to $35 M for future M&A.

  • Balance Sheet Highlights

  • Cash & cash equivalents: $36.5 M (up from $26.4 M at end‑2024).

  • Total assets: $555.3 M; total liabilities: $459.8 M; shareholders’ equity: $95.5 M.

  • Operational Highlights

  • Maintained leadership in New Jersey; top‑ranked Apothecarium store in Phillipsburg.
  • Launched new preroll assortment in NJ – category sales up 32% QoQ.

  • Continued divestiture of Michigan assets, target completion by year‑end 2025.

  • Shareholder Actions

  • Board authorized a normal course issuer bid to repurchase up to $10 M of common shares over the next 12 months.

Notable Quotes

“I’m pleased to report that both gross margins and Adjusted EBITDA margins improved meaningfully… our fundamentals are improving, our balance sheet remains strong…” – Jason Wild, Executive Chairman.

Materiality Assessment: Material – Positive (significant financial performance improvement, major refinancing, and strategic M&A capacity).

Read the original news release →

More from TERRASCEND CORP. J

Jun 30, 2026 · 08:30

Small accretive NJ acquisition and reverse-split proxy fail to offset lingering debt and Michigan receivership overhang.

M&A / Property Jun 29, 2026 · 11:00

TerrAscend Files Proxy for Reverse Split; Uplisting Remains a Mechanical Step, Not a Fundamental Catalyst

Other Jun 25, 2026 · 16:00

Debt maturity extension and M&A war chest, but conversion discount and Michigan receivership cloud the balance sheet.

Financings Jun 05, 2026 · 14:26

TerrAscend Schedules Special Meeting of Shareholders in Preparation for U.S. Stock Exchange Uplisting

Other May 07, 2026 · 07:10

TerrAscend Confirms Cash Flow Streak Amidst Regulatory Tailwinds

Earnings Apr 27, 2026 · 08:35

TerrAscend Stabilizes Cash Flow Amidst Cannabis Sector Volatility

Earnings